Medgenics, Inc. (AMEX: MDGN) is on The StockGuru Leader Board today.  The stock closed up 8.08% on Thursday.

Volume was 17,516 shares traded.

Join in on the Discussion about MDGNhttp://members.stockguru.com/stocks/mdgn/

About the Company:

Medgenics, Inc., a commercial-stage biopharmaceutical company, focuses on providing protein therapies. The company develops the Biopump Platform, a proprietary technology, which uses the patient’s own tissue to continuously produce and deliver the patient’s own protein therapy. It is designed to provide protein therapy to treat a range of chronic diseases, including anemia, hepatitis C, hemophilia, multiple sclerosis, arthritis, pediatric growth hormone deficiency, obesity, diabetes, and other chronic diseases or conditions. The company’s product line includes EPODURE, a Biopump producing erythropoietin in Phase I/II clinical trial to treat anemia in patients with chronic kidney disease; INFRADURE, a Biopump producing interferon-alpha in preclinical stage for the treatment of hepatitis-C; and HEMODURE, a Biopump to produce clotting Factor VIII for the treatment of hemophilia. Medgenics, Inc. was founded in 2000 and is based in San Francisco, California.

About the StockGuru Leader Board:

We watch for stocks moving up and creating a positive momentum in the market.  We are not compensated for coverage.

Feel free to suggest a stock for coverage if you see it breaking out.  Contact: [email protected].

StockGuru.com
StockGuruCanada.com
Shareholdervision.com
BoldStocks.com
IR Affiliates – IRIR.co
StoneBridge Web & SEO – StonebridgeIQ.com

All content on StockGuru.com is original content – with the exception of client news releases. All content is (C) Copyright 2002 to 2012 StockGuru. No content may be used in whole or in part without the express written consent of our Publisher. We encourage web sites interested in our content to offer a reciprocal exchange agreement in exchange for use of some of our content. We do not offer advance approval, but contact our Publisher if you have an interest in repropagating our content. Contact as at: [email protected] or (469) 252-3030. Mailing address: 1601 Berwick Drive; McKinney, Texas 75070